Indiana

Back to map

Showing 1-10 of 14 grants

Title Institution Researcher Program Duration Total Award Amount
Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D Indiana Biosciences Research Institute Michael Kalwat Cures 01-December-2024 to 30-November-2027 $748,169.00
Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation Indiana Biosciences Research Institute Isabela Lovizutto Iessi Longo Cures 01-March-2023 to 28-February-2026 $135,307.11
ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY Indiana Biosciences Research Institute Erica Cai Cures 01-March-2023 to 29-February-2028 $999,737.71
Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity Indiana Biosciences Research Institute Erica Cai Cures 01-September-2023 to 31-August-2026 $499,934.12
Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D Neurodon LLC Russell Dahl Cures 01-June-2022 to 31-October-2025 $920,000.00
CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes Trustees of Indiana University Viral Shah Cures 01-November-2024 to 31-October-2027 $900,000.00
Relationship of Time-In-Range with microvascular complications in type 1 diabetes Trustees of Indiana University Viral Shah Improving Lives 01-February-2024 to 31-July-2025 $71,123.95
Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study Trustees of Indiana University Viral Shah Improving Lives 01-September-2025 to 31-August-2028 $1,603,777.39
Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes Trustees of Indiana University Jon Piganelli Cures 01-August-2023 to 30-June-2025 $334,595.29
SOLUBLE LYMPHOCYTE ACTIVATION GENE-3 (s-LAG-3): A POTENTIAL SURROGATE MARKER FOR TYPE-1 DIABETES PROGRESSION AND IMMUNOTHERAPY SUCCESS Trustees of Indiana University Jon Piganelli Cures 01-July-2025 to 30-June-2026 $153,000.00